Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy

Diabetic retinopathy (DR) is a common complication of diabetes and leads to blindness. Anti‐VEGF is a primary treatment for DR. Its therapeutic effect is limited in non‐ or poor responders despite frequent injections. By performing a comprehensive analysis of the semaphorins family, we identified th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EMBO Mol Med
Auteurs principaux: Wu, Jie‐hong, Li, Ya‐nan, Chen, An‐qi, Hong, Can‐dong, Zhang, Chun‐lin, Wang, Hai‐ling, Zhou, Yi‐fan, Li, Peng‐Cheng, Wang, Yong, Mao, Ling, Xia, Yuan‐peng, He, Quan‐wei, Jin, Hui‐juan, Yue, Zhen‐yu, Hu, Bo
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7005627/
https://ncbi.nlm.nih.gov/pubmed/31943789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201810154
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires